Statement by Research!America President and CEO Mary Woolley on NIH’s bypass budget for Alzheimer’s disease

Tuesday, July 28, 2015
A photo of the US Capitol

The National Institutes of Health’s (NIH) first ever ‘Bypass Budget’ for Alzheimer’s disease and related dementias is critically important.  By providing a blueprint for optimal federal action against this insidious health threat in FY 2017, it demonstrates what can be done when resources are sufficient. The bypass budget concept also underscores a tragic fact:  our nation is slow-walking solutions for a host of deadly and disabling diseases by underinvesting in research. The scientific opportunity is palpable and the benefits of faster medical progress are profound. By advancing legislation like the 21st Century Cures Act and boosting annual appropriations for NIH, Congress and the White House can close the distance between what is, and what is possible.  Given the havoc diseases like Alzheimer’s wreak on our nation, bold action can’t come a moment too soon.

Media Contacts

Robert Shalett
Director of Communications 

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient